Glycogen storage disease type I risk factors: Difference between revisions
No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Glycogen storage disease type I}} | {{Glycogen storage disease type I}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}}{{Anmol}} | ||
{{ | |||
==Overview== | ==Overview== | ||
The most potent risk factor in the development of glycogen storage disease type 1 is a sibling with glycogen storage disease type 1. | |||
==Risk Factors== | ==Risk Factors== | ||
Revision as of 19:06, 21 November 2017
|
Glycogen storage disease type I Microchapters |
|
Differentiating Glycogen storage disease type I from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Glycogen storage disease type I risk factors On the Web |
|
American Roentgen Ray Society Images of Glycogen storage disease type I risk factors |
|
Directions to Hospitals Treating Glycogen storage disease type I |
|
Risk calculators and risk factors for Glycogen storage disease type I risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]
Overview
The most potent risk factor in the development of glycogen storage disease type 1 is a sibling with glycogen storage disease type 1.
Risk Factors
The most potent risk factor in the development of glycogen storage disease type 1 is a sibling with glycogen storage disease type 1.